Open AccessMirvetuximab Soravtansine With Chemo Induces Encouraging Responses in Ovarian Cancer
Author(s) -
Mark L. Fuerst
Publication year - 2020
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000723568.85826.dc
Subject(s) - carboplatin , bevacizumab , medicine , ovarian cancer , dosing , oncology , gastroenterology , cancer , chemotherapy , cisplatin